AGBL offers library preparation kits that expand the applications of NGS to the field of pharmacogenetics and diagnostic oncology. All kits at CE-IVD which ensures diagnostic compliance.
4bases NGS kits are based on targeted Next Generation Sequencing for sensitive detection of clinically actionable mutations from limiting DNA quantities including FFPE, fresh-frozen tissues, Fine Needle Aspiration , small biopsies, cell free circulating DNA.
Currently 4bases kits are available for colorectal, lung and melanoma cancer and are designed to identify genetic anomalies of the cancer to direct drug therapy decisions. 4bases also plan to develop kits for other cancers , hereditary cancer syndromes and non-oncological diseases.